Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.

Mani, Helen

Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions. [electronic resource] - Thrombosis and haemostasis Jan 2013 - 127-36 p. digital

Publication Type: Journal Article

2567-689X

10.1160/TH12-04-0228 doi


Administration, Oral
Anticoagulants--administration & dosage
Arthroplasty, Replacement, Hip--adverse effects
Arthroplasty, Replacement, Knee--adverse effects
Biomarkers--blood
Blood Coagulation--drug effects
Blood Coagulation Factors--antagonists & inhibitors
Blood Coagulation Tests--methods
Chromatography, High Pressure Liquid
Chromogenic Compounds
Drug Administration Schedule
Enzyme-Linked Immunosorbent Assay
Factor Xa--metabolism
Factor Xa Inhibitors
False Positive Reactions
Humans
Morpholines--administration & dosage
Nephelometry and Turbidimetry
Predictive Value of Tests
Reproducibility of Results
Rivaroxaban
Tablets
Tandem Mass Spectrometry
Thiophenes--administration & dosage
Thrombophilia--blood
Thrombosis--blood
Time Factors
Treatment Outcome